OmniAb (OABI) Accumulated Expenses (2021 - 2026)
OmniAb (OABI) reported Accumulated Expenses of $4.0 million for Q1 2026, up 12.53% year-over-year from $3.6 million in Q1 2025, and down 35.92% quarter-over-quarter from $6.3 million in Q4 2025.
OmniAb (OABI) Accumulated Expenses (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Accumulated Expenses data on file, last reported at $4.0 million in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $4.0 million, up 12.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 million (up 12.53% YoY), and the FY2025 annual result was $6.3 million, up 2.44% from the prior year.
- Accumulated Expenses eased to $4.0 million in Q1 2026 per OABI's latest filing, from $6.3 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $7.1 million in Q4 2023 and troughed at $314153.0 in Q1 2022.
- A 5-year average of $4.3 million and a median of $4.7 million in 2025 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses slipped 29.15% in 2022, then jumped 1974.46% in 2023.
- A 5-year view of Accumulated Expenses shows it stood at $5.6 million in 2022, then gained by 27.19% to $7.1 million in 2023, then decreased by 13.12% to $6.1 million in 2024, then advanced by 2.44% to $6.3 million in 2025, then slumped by 35.92% to $4.0 million in 2026.
- Business Quant data shows OABI's Accumulated Expenses at $4.0 million in Q1 2026, $6.3 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.03 Mn |
| Dec 31, 2025 | 6.29 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 3.58 Mn |
| Dec 31, 2024 | 6.14 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 4.55 Mn |
| Mar 31, 2024 | 4.03 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Sep 30, 2023 | 6.52 Mn |
| Jun 30, 2023 | 4.93 Mn |
| Mar 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 5.56 Mn |
| Sep 30, 2022 | 314,154.00 |
| Jun 30, 2022 | 314,153.00 |
| Mar 31, 2022 | 314,153.00 |
| Dec 31, 2021 | 3.75 Mn |
| Sep 30, 2021 | 42,677.00 |
| Jun 30, 2021 | 443,381.00 |